
Pathology Outlines - p16
Jan 25, 2024 · A. p16 immunohistochemistry is not recommended as a routine adjunct assessment when the biopsy interpretation is negative, CIN I or CIN III. Strong and diffuse block staining for p16 supports a categorization of precancerous disease. Any identified p16 positive area must meet H&E morphologic criteria for a high grade lesion to reinterpreted as ...
Pathology Outlines - HPV (Human papillomavirus)
Expression of p16 above 67% of the epithelium is associated with negative E4, while expression of p16 up to 67% of the epithelium is associated with positive E4 (p < 0.001) (Cancer Med 2020;9:2454) Dual marker approach with p16 / E4 may help grade cervical intraepithelial neoplasia (CIN) lesions and improve disease stratification ( Mod Pathol ...
Pathology Outlines - Staging-oropharynx & hypopharynx
Nov 21, 2019 · If p16 testing is not performed on oropharyngeal carcinoma, that case is staged according to the system for p16- cancers AJCC level of evidence: II Cancers staged using the oropharynx (p16-) and hypopharynx staging system include p16- squamous cancers of the oropharynx Oropharyngeal cancers without a p16 immunostain performed
Pathology Outlines - Endometrioid carcinoma
Sep 3, 2020 · p16 mosaic (patchy and weak nuclear / cytoplasmic expression) To be considered positive, p16 must have strong, diffuse, block-like nuclear and cytoplasmic positivity throughout the area of interest Caveat: high grade (FIGO 3) tumors can show aberrant expression (Gynecol Oncol 2004;94:449, Am J Surg Pathol 2009;33:1504)
Pathology Outlines - Stains & CD markers
6 days ago · P glycoprotein p16 p21 p40 p53 p57 p62 (pending) p63 p120 catenin P504S Pan-TRK PAP PAS PAX2 PAX5 PAX8 PCNA PD-1 PDL1 22C3 PDL1 SP142 PDL1 SP263 (pending) PECAM1 perforin (pending) PGP9.5 (pending) PHLDA1 (pending) phosphohistone H3 Pit1 PLAG1 PLAP PMS2 podoplanin PRAME prealbumin (pending) progesterone receptor (PR) …
Pathology Outlines - HSIL / CIN II / CIN III
Mar 29, 2021 · p16: diffuse and strong nuclear and cytoplasmic reactivity (block type staining); improper use / interpretation may lead to overdiagnosis of HSIL Surgical excision is the treatment of choice, except during pregnancy or CIN II in females < 25 years old
Pathology Outlines - HPV associated SIL
Jan 6, 2021 · p16 usually negative but may be rarely positive in block type pattern in the lower third of the epithelium Ki67 is elevated, mostly in the lower third of the epithelium, preserved compartments Immunohistochemically positive HPV detection in koilocytic cells in a subset of cases depending on the antibody used
HPV associated cervical squamous cell carcinoma
Dec 11, 2023 · Negative for p16 and RNA in situ hybridization for high risk human papillomavirus Clear cell carcinoma (versus squamous cell carcinoma with cytoplasmic clearing): Papillary, tubulocystic and solid growth patterns, hobnail cells, no squamous differentiation Positive for HNF-1B and Napsin A, negative for p63. Adenoid basal carcinoma:
Pathology Outlines - Serous carcinoma
Jan 30, 2020 · The carcinoma shown in the image above, which involves the surface of an endometrial polyp, shows strong and diffuse positivity for p53 and p16. Which of the follow is true regarding the above carcinoma? Likely arose in a patient less than 30 years of age Considered an estrogen dependent endometrial carcinoma
Pathology Outlines - Diffuse mesothelioma (pleura)
Mar 4, 2021 · Homozygous deletion of CDKN2A (p16) by FISH All mesothelioma Epithelioid mesothelioma Sarcomatoid mesothelioma 58 - 62 48 - 78 67 100; Loss of BAP expression or homozygous deletion of CDKN2A All mesothelioma Epithelioid mesothelioma Sarcomatoid mesothelioma 58 - 92 92 67 - 100 100